Sign In
Buy BCRX
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
MHRA Grants HAE Patients Early Access to BioCryst's Berotralstat in United Kingdom
08:15am, Friday, 30'th Oct 2020
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom's Medicines and Healthcare products Regulatory Age
Biocryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology
07:00am, Wednesday, 28'th Oct 2020
RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present five abstracts and one Distinguished Industr
BioCryst Coming Of Age
11:18pm, Tuesday, 27'th Oct 2020
Berotralstat is BioCryst's first rare disease drug coming to market with its PDUFA scheduled for December 3. Berotralstat is up for final Japanese approval on October 30.
BioCryst Pharmaceuticals' (NASDAQ:BCRX) Shareholders Are Down 62% On Their Shares
03:41pm, Monday, 17'th Aug 2020
We think intelligent long term investing is the way to go. But no-one is immune from buying too high. Zooming in on an...
Here's Why BioCryst Pharmaceuticals Jumped Higher Today
05:48pm, Thursday, 13'th Aug 2020
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are up 14.5% at 1:16 p.m. after the biotech's new CFO, Anthony Doyle, purchased 54,000 shares of the company at $4.08 per share. As they say, there
Do Options Traders Know Something About BioCryst Pharmaceuticals (BCRX) Stock We Don't?
12:54pm, Tuesday, 11'th Aug 2020
Investors need to pay close attention to BioCryst Pharmaceuticals (BCRX) stock based on the movements in the options market lately.
BioCryst Pharmaceuticals: Enter Now Before The End Of Next September 2020 (NASDAQ:BCRX)
01:59pm, Monday, 10'th Aug 2020
On August 6, BioCryst Pharmaceuticals reported Q2 results. We were all hoping to find some data from Part 1 of the Galidesivir trial that is being conducted in Brazil to evaluate efficacy and safety a
BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Misses Revenue Estimates
01:55pm, Thursday, 06'th Aug 2020
BioCryst (BCRX) delivered earnings and revenue surprises of 14.29% and -9.43%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BioCryst Reports Second Quarter 2020 Financial Results and Upcoming Key Milestones
11:00am, Thursday, 06'th Aug 2020
—ORLADEYO™ (berotralstat) approvals expected in U.S. and Japan in Q4 2020, EU in early 2021— —200 mg/400mg BCX9930 data from treatment-naïve PNH patients expected in Q3 2020, 200 mg/400mg da
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11:00am, Tuesday, 04'th Aug 2020
RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors grante
Is BioCryst Pharmaceuticals Stock a Buy?
03:19pm, Monday, 03'rd Aug 2020
Small-cap biotech BioCryst Pharmaceuticals (NASDAQ: BCRX) is among them, and its COVID-19 drug is currently in early stage clinical testing. While most companies working on a COVID-19 treatment have
FDA Grants Fast Track Designation for BCX9930 in PNH
11:00am, Monday, 03'rd Aug 2020
RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track des
BioCryst Pharmaceuticals (NASDAQ:BCRX) Rating Lowered to Sell at BidaskClub
05:16am, Monday, 03'rd Aug 2020
BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, BidAskCl
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
